Bayer: Science For A Better Life
Contact us | RSS | Sitemap  | Dansk  | Norsk  | Svenska
 
Special Interests

Profile and Organization

Names | Figures | Facts

Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and high earning power.

Organization

Bayer AG defines common values, goals and strategies for the entire Group. The three subgroups and three service companies operate independently, led by the management holding company. The Corporate Center supports the Group Management Board in its task of strategic leadership.





Business operations are the responsibility of the subgroups:

 

Central service functions are combined into three service companies:

 

Corporate Governance

Dual governance system with the following governance bodies:

 
Board of Management:            5 members, Chairman: Werner Wenning 
Supervisory Board:             20 members, Chairman: Dr. Manfred Schneider


Products

The Bayer Group markets some 5,000 products. Best-sellers include:



Locations

Bayer is represented around the world by 302* companies. Global headquarters are in Leverkusen, Germany.

* fully consolidated subsidiaries (as of Dec. 31, 2009)
 

Workforce

On December 31, 2009, the Bayer Group had 108,400 employees worldwide (2008: 108,600). North America accounted for 16,300 of these employees, while 21,600 were based in Asia-Pacific, 16,000 in Latin America/Africa/Middle East and 54,500 in Europe. In Germany we had 36,700 employees, who made up 33.9 percent of the Group workforce.


108,400 employees worldwide (as of December 31, 2009), including:

 54,500 in Europe 
 16,300 in North America
 21,600 in Asia/Pacific
 16,000 in Latin America/Africa/Middle East



Bayer Stock



Bayer Group Key Data

Bayer Group                                                               

        2008       
€ million

      2009  
        € million   

          Change
          %

Net sales

32,918

31,168

-5.3

EBITDA 1

6,266

5,815

-7.2

EBITDA before special items

6,931

6,472

-6.6

EBIT 2

3,544

3,006

-15.2

EBIT before special items

4,342

3,772

-13.1

Income before income taxes

2,356

1,870

-20.6

Net income

1,719

1,359

-20.9

Earnings per share (in €) 3

2.22

1.70

-23.4

Gross cash flow 4

5,295

4,658

-12.0

Net cash flow 5

3,608

5,375

+49.0

Capital expenditures

1,982

1,669

-15.8

Research and development expenses

2,653

2,746

+3.5

Dividend per Bayer AG share (€)

1.40

1.40

0.0

 


Sales by segment in percent, 2009 (2008 in parentheses)

  
  Reconciliation 3.4% (3.7%)
   
 

HealthCare 46.5% (48.7%)
Pharmaceuticals 30.4% (32.8%)
Consumer Health 16.1% (15.9%)

   
CropScience 23.5% (26.9%)
Crop Protection 17.8% (22.0%)
Environmental Science/BioScience 5.7% (4.9%)
   

MaterialScience 26 .6% (20.7%)

                                               

Current financial reports


Print
Search

Advanced Search
Bayer Websites Worldwide
Quick links